SpringWorks Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SWTX for the last quarter is 59.73 M USD, and it's 184.36% higher compared to the previous quarter. The net income of Q2 24 is -39.92 M USD.